Aventi Urinary Complete (Canada)

Company: Aventix

Veterinary Health Product

Promotes a healthy urinary tract

NN.D9O0

Active ingredients per chewable tablet: glucosamine HCl (shrimp exoskeleton) 500 mg, Camellia sinensis (green tea) 89.30 mg, Vaccinium macrocarpon (cranberry extract) 60 mg, fermentation product from Saccharomyces cerevisiae 10.70 mg, melon by-product (fruit) 10 mg.

Inactive Ingredients

maltodextrin, silicon dioxide, dicalcium phosphate, magnesium stearate, proprietary flavouring enhancer (vegetable blend)

Dosing recommendations: Administer orally according to the following daily quantities, based on the pet’s body weight. The daily quantity can be given directly into the mouth, or crushed and mixed with food.

INITIAL DOSING: Twice a day for up to 30 days

LONG-TERM DOSING: Once a day for a minimum of 10 consecutive days per month

Or as directed by your veterinarian.

Aventi Urinary Complete can be administered alone or in conjunction with usual therapies.

Cautions: Do not use in pregnant or lactating animals. Do not use in animals with heart, kidney, or thyroid disease.

Warnings

Do not remove the chewable tablet from its packaging until ready to use. Store in a dry place away from direct sunlight. Keep out of reach of children.

Notifier:

AVENTIX, Burlington, Ontario, Canada, L7L 5R7

www.aventix.ca

Question or side effect report:

1-877-909-2242

Manufactured in Italy by:

ACEL pharma S.r.l. - via A. Manzoni 2, 10092 Beinasco (TO)

Id N°: αIT000194TO

Formerly: Candioli PHARMA

Quality Statement

ACEL pharma is annually inspected by Certiquality, in accordance with the safety requirements set by the US Code of Federal Regulations (title 21, volume 2, part 111, from May 1st, 2017) for the manufacturing activity of dietary supplements for pets. The Quality Management System of the company is in compliance with the standard UNI EN ISO 9001:2015.

CPN: 1301096.0